Pharvaris expects pivotal HAE study data in third quarter 2026
Go back to Pharvaris expects pivotal HAE study data in third quarter 2026| (NASDAQ: PHVS) | Delayed: 31.54 +0.13 (0.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.41 | 52 Week High | $ | |||
| Open | $31.38 | 52 Week Low | $ | |||
| Day High | $32.08 | P/E | N/A | |||
| Day Low | $31.30 | EPS | $ | |||
| Volume | 347,675 | |||||



